Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
about
Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapyRedox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles
P2860
Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Microparticles containing erlo ...... of non-small cell lung cancer.
@en
Microparticles containing erlo ...... of non-small cell lung cancer.
@nl
type
label
Microparticles containing erlo ...... of non-small cell lung cancer.
@en
Microparticles containing erlo ...... of non-small cell lung cancer.
@nl
prefLabel
Microparticles containing erlo ...... of non-small cell lung cancer.
@en
Microparticles containing erlo ...... of non-small cell lung cancer.
@nl
P2093
P2860
P50
P1476
Microparticles containing erlo ...... of non-small cell lung cancer
@en
P2093
Elhameh Nemati
Jafar Ezzati Nazhad Dolatabadi
Zahra Bakhtiary
P2860
P304
P356
10.1080/03639045.2017.1310223
P407
P577
2017-04-10T00:00:00Z